Health
FDA Halts Regenxbio Gene Therapy Trial Again Amid Safety Issues
By Editor • August 24, 2026 • 1 min read
The FDA has paused Regenxbio's gene therapy trials for Hunter syndrome due to safety concerns after five patients showed spine masses.
Read more